Ashish Patel
Ashish is co-founder of CareSet Systems. An entrepreneur and healthcare data transparency advocate, Ashish also founded the DocGraph Journal, bringing together the Healthcare Data Science community along with Politico and ProPublica to publish data sets for scientific advancement. Ashish is currently working to decode Medicare Claims data for Pharmaceutical companies, helping analyze provider teaming, and building robust networks.
Regulatory Foreshadowing From JPM Healthcare 2022
The 40th Annual J.P. Morgan Healthcare Conference, January 10-13, brought strategic insights. This year, I spoke with Deloitte, specifically partners in the regulatory practice and leaders of the regulatory strategies group. This team seeks discussion with healthcare executives who look at the regulatory environment as input to strategy endeavors. As an industry as heavily regulated…
Read MoreHCPCS Code Change Transforms Landscape of Preventative Care
Until now, healthcare providers spent up to 40% of their time on administrative tasks, largely due to the complexity of the code system. Spending more time on paperwork meant spending less time with patients which was frustrating for everyone. Recently, the AMA revised the definitions for Evaluation and Management (E/M) codes in the Current Procedural…
Read MoreFinding, Treating, and Curing Rare Diseases
Picture the following scenario: A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these…
Read MoreTransparency in Specialty Pharmacy Supply Chains
Navigating the world of Specialty Pharmacy is complex and riddled with information asymmetry. But, it just got a lot easier. CareSet provides the experience and unblocked data to connect your new medication with the Specialty Pharmacies and prescribing physicians you need to reach your target patient populations. Characterizing the industry, the co-founder and former president…
Read MoreUnblocking Part D, MarketView
In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself. CareSet’s Part D Targeting product provides brand teams clarity using Medicare’s unblocked claims data. This allows us to…
Read MoreNCPDP PTI Roundtable for VBA
On 8/30/21, I had the honor of co-chairing the first roundtable from NCPDP’s (National Council for Prescription Drug Programs) PharmTechnology Innovation (PTI) Accelerator. Our presenters discussed the different elements related to value-based agreements (VBA). Our incredible speakers included: John W. Hill, MBAHCM, CNED, Executive Vice President & GM with the National Council for Prescription Drug…
Read MoreWhich Medicare Physician is the Best Doctor to Educate About Your Medication or Medical Device?
While pharma marketers continue to navigate their brand through COVID-19, non-personal promotion appears to be the best approach for the time being. In order to reach optimal efficiency, marketers will want to utilize the best list of providers for their brand. Publicly available datasets, as well as commercially available datasets, are all over the internet.…
Read MoreAHA, Merck, Novartis, J&J & CareSet
Amongst the improved programming of SXSW healthcare, CareSet’s SXSW panel is sandwiched between AHA and Merck events. The infamous Fred Trotter moderates a discussion about new school cardiovascular care lead by four executive experts. We are all affected and will be there. Date: March 10th, 2018 Time: 11:00AM Duration: 60 minutes Venue: Austin Convention Center Room: 6AB…
Read More